ANALYSIS: The idea of AI is now so powerful a blog post about its hypothetical effects moved markets this week. The risks may lie in a different direction.
ANALYSIS: An Infratil unit is double-teaming with its ASX-listed counterpart to challenge investment from clinicians.
ANALYSIS: While property developer Winton is sitting pretty after a perfectly timed IPO, its investors won’t be so happy.
ANALYSIS: In New Zealand’s unregulated market, it’s all they’ve got to go on.
ANALYSIS: A farm investment company has given its small shareholders an uncomfortable ride.
ANALYSIS: With green bonds not necessarily green or cheaper for issuers, higher standards will be required to deliver on promises.
ANALYSIS: As Genesis mulls burning wood pellets at Huntly power station, their contribution to renewable energy targets is under fire in Europe.
ANALYSIS: The Ombudsman rules a secret DIA report can stay secret.
ANALYSIS: A deal to sell Evolve Education’s NZ business raises questions of value for shareholders.
Expectations of the gains from Covid for Fisher & Paykel were bullish, until they weren’t.